Related Experiment Video
Updated: Jun 10, 2026
09:16
Array Comparative Genomic Hybridization (Array CGH) for Detection of Genomic Copy Number Variants
Published on: February 21, 2015
Microarray-based comparative genomic hybridization (array-CGH) as a useful tool for identifying genes involved in
Yolanda Ruano1, Manuela Mollejo, Angel Rodríguez de Lope
1Molecular Pathology Research Unit, Virgen de la Salud Hospital, Toledo, Spain.
Methods in Molecular Biology (Clifton, N.J.)
|August 20, 2010
Summary
Glioblastomas show genomic alterations affecting DNA copy number. Microarray-based comparative genomic hybridization (array-CGH) analyzes these imbalances, identifying candidate genes in tumors.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Glioblastomas (GBs) are characterized by genomic alterations, specifically changes in DNA sequence copy number.
- Understanding these copy number variations is crucial for identifying potential therapeutic targets.
Purpose of the Study:
- To utilize array-comparative genomic hybridization (array-CGH) for high-resolution analysis of genomic copy number imbalances in Glioblastoma tumors.
- To identify amplicons and candidate genes exhibiting recurrent copy number changes in GBs.
Main Methods:
- Employed microarray-based comparative genomic hybridization (array-CGH).
- Hybridized genomic DNA onto cDNA microarrays for analyzing genomic copy number imbalances.
- Reviewed thousands of genes for high-resolution analysis.
Main Results:
- Successfully identified genomic copy number alterations in Glioblastoma tumors.
- Defined specific amplicons associated with Glioblastoma.
- Identified candidate genes with recurrent genomic copy number changes.
Conclusions:
- Array-CGH is an effective high-throughput method for detecting genomic copy number alterations in Glioblastoma.
- This approach aids in the discovery of candidate genes critical to Glioblastoma development and progression.
